Mark, Morton F.; Imparato, Anthony M.; Hutner, S. H.; Baker, Herman
August 1963
Angiology;Aug1963, Vol. 14 Issue 8, p383
Academic Journal
The relative toxicity of seven radiopaque agents presently used in angiography was determined, with the ciliate protozoan Tetrahymena pyriformis as the test organism. In the first group of experiments, the contrast agents selected were those for which adequate studies in higher animals were available for comparison. In the final studies the relative toxicity of two new compounds, methylglucamine methalamate and sodium methalamate, was determined. Forty-eight-hour cultures of the ciliate were suspended in 0.5 N saline solution and were exposed to varying concentrations of the radiopaque agents. The index of toxicity was reduction in motility, estimated by direct microscopic observation. The results indicated that of the older compounds, sodium diatrizoate and methylglucamine diatrizoate are the least toxic, sodium acetrizoate the most toxic, and sodium diprotrizoate and iodopyracet, intermediate. For the new agents, the results with this method indicate that methylglucamine methalamate is somewhat less toxic than the diatrizoates, and the toxicity of sodium methalamate is of the same order as that for iodopyracet.


Related Articles

  • Inflammatory markers increase following exposure to radiographic contrast media. Laskey, W.K.; Gellman, J. // Acta Radiologica;Sep2003, Vol. 44 Issue 5, p498 

    Purpose: Increased levels of markers of systemic inflammation have been noted in patients following coronary angiographic procedures. The purpose of the present study was to examine the influence of the type of the angiographic procedure as well as the type of radiographic contrast...

  • Multicenter phase-II trial of safety and efficacy of NC100150 for steady-state contrast-enhanced peripheral magnetic resonance angiography. Leiner, Tim; Ho, Kai Yiu J. A. M.; Ho, Vincent B.; Bongartz, Georg; Mali, Willem P. T. M.; Rasch, Wenche; van Engelshoven, Jos M. A. // European Radiology;Jul2003, Vol. 13 Issue 7, p1620 

    The aim of this study was to test the safety and efficacy of NC100150 injection for steady-state contrast-enhanced peripheral MR angiography in a multicentre phase-II trial. Thirty-three patients underwent steady-state NC100150 enhanced MR angiography (5 mg Fe/kg body weight) of the aortoiliac...

  • Iomeprol: A Review of its Use as a Contrast Medium. Dooley, M.; Jarvis, B. // Drugs;May2000, Vol. 59 Issue 5, p1169 

    Iomeprol is a nonionic, monomeric iodinated contrast medium. Unlike the older ionic agents, iomeprol has low chemotoxicity, osmolality and viscosity and high water solubility. Compared with other nonionic contrast media, the osmolality and viscosity are lower and the water solubility is reported...

  • MORPHOLOGIC CHANGES IN VESSEL ENDOTHELIA CAUSED BY CONTRAST MEDIA. Zinner, G.; Gottlob, R. // Angiology;Aug1959 Part 1, Vol. 10 Issue 4, p207 

    Investigates the effect of contrast media on the alteration of blood vessel endothelia. Morphologic changes found in the vascular tissue after utilization of the medium; Mechanism for the local damage in the vessel intima; Means to prevent damage by the contrast medium during angiography.

  • Mechanochemical Synthesis of Yttrium and Lanthanum Tantalates. Molchanov, V. V.; Zuev, M. G.; Plyasova, L. M.; Bogdanov, S. V. // Inorganic Materials;Jan2004, Vol. 40 Issue 1, p73 

    The phase changes in the Y2O3–Ta2O5 and La2O3–Ta2O5 systems during mechanical activation and subsequent heat treatment are investigated. Y2O3 and Ta2O5 are shown to react during mechanical activation to form Y3TaO7 . Calcination of activated mixtures leads to the formation of YTaO4...

  • Adverse Effects of Contrast Media: Incidence, Prevention and Management. Thomsen, H.S.; Bush, W.H.J. // Drug Safety;Oct1998, Vol. 19 Issue 4, p313 

    Although contrast media are relatively well tolerated, a non-life-threatening, moderate reaction requiring some treatment occurs in 1 to 2% of patients receiving ionic high-osmolar contrast media and in 0.2 to 0.4% of patients receiving non-ionic low-osmolar contrast media. Severe,...

  • Allergic reactions at repeat femoral angiography with ioxaglate. Nilsson, S.; Bergstrand, L.; Erikson, U.; Johansson, J.; Smedby, Ö.; Walldius, G.; Smedby, O // Acta Radiologica;Nov2001, Vol. 42 Issue 6, p608 

    Purpose: To study the occurrence of allergy-like reactions at angiography, repeated several times, and, secondly, to evaluate the effect of prophylactic treatment in individuals who had earlier experienced such reactions. Material and Methods: One hundred and...

  • MRA WITH NEW GADOLINIUM CHELATES. Knopp, M.V.; Flomer, F.; Schoenberg, S.; Kobligk, H. Von Tenng; Hentrich, R. // Acta Radiologica;Apr2000 Supplement 422, Vol. 41, p25 

    Studies the use of Gadobenate dimeglumine, a gadolinium-chelate, as a contrast media for magnetic resonance angiography. Safety profile; Concentration; Target applications.

  • CARDIOVASCULAR IMAGING WITH ANGIOMARK. Yucel, E.K. // Acta Radiologica;Apr2000 Supplement 422, Vol. 41, p27 

    Describes the properties of AngioMark, a small-molecular-weight gadolinium chelate which binds reversibly to serum albumin. Application as a contrast media in magnetic resonance angiography; Clinical trial status.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics